General Infectious Disease News Articles

Infectious Dis.

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Dohmen W et al. - The aim of this study is to present an overview of azithromycin (AZI)-basedHelicobacter pylori eradication therapies which have been used to date. The most successful combination therapy found in this analysis consisted of pantoprazole in combination with AZI and tinidazole, given as a single dose 2 h after breakfast for 6 days. This study shows that of the AZI therapies used so far, combinations of AZI and tinidazole are the most successful at eradicatingH. pylori.

Related Articles

Peptic ulcer disease and helicobacter pylori infection at kano, nigeria
The Internet Journal of Gastroenterology, 11/11/09    Relevance Score: 69%%

Reactive Nitrogen Species Mediate DNA Damage in Helicobacter pylori-Infected Gastric Mucosa
Helicobacter, 11/09/09    Relevance Score: 68%%

Helicobacter pylori infection in children: population-based age-specific prevalence and risk factors in a developing country
Acta Pediatrica, 10/28/09    Relevance Score: 68%%

In-vitro interaction of l-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability
Journal of Pharmacy and Pharmacology, 10/14/09    Relevance Score: 68%%

Analysis of Clarithromycin Resistance and CagA Status in Helicobacter pylori Using Feces from Children in Thailand
Journal of Clinical Microbiology, 10/08/09    Relevance Score: 68%%

Today in GI Infectious Disease...keeping you current

Hepatitis B therapies and antiviral resistance detection and management
Expert Review of Gastroenterology & Hepatology, 12/01/09

Evolution of new variants of Vibrio cholerae O1
Trends in Microbiology, 12/01/09

Role of the Host Defense System and Intestinal Microbial Flora in the Pathogenesis of Necrotizing Enterocolitis
Surgical Infections, 12/01/09